NeoGenomics 3Q NGS Rev Growth ~28%
NeoGenomics reported third-quarter Next-Generation Sequencing (NGS) revenue growth of approximately 28%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.